Point of Care Diagnostics Market Report and Opportunities 2031

Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring {Blood Glucose Meter, Lancet, and Strips}), Infectious Disease Testing {HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others}), Cardiometabolic Testing {Cardiac Troponin (cTn) Test, Myoglobin Test, and Others}), Pregnancy and Fertility Testing, Coagulation Testing, Tumor/Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities {Hospitals and Clinics, Diagnostic Centers, and Others}, Homecare, and Others) and Geography

Publication Month : May 2025

  • Report Code : TIPRE00006394
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 483
Inquire Before Buy

PRICING

$4450

$3560

The Point of Care Diagnostics Market size is projected to reach US$ 88.83 billion by 2031 from US$ 37.93 billion in 2024. The market is estimated to register a CAGR of 13.0% during 2024–2031. The Integration Of Artificial Intelligence (AI) and Machine Learning (ML) is likely to bring new trends to the market in the coming years.

Point of Care Diagnostics Market Analysis

The Point of Care (POC) Diagnostics Market growth is driven by the increasing prevalence of infectious diseases, which has heightened the demand for rapid and accurate diagnostic solutions. Technological advancements and the integration of artificial intelligence and machine learning are enhancing the efficiency and accuracy of testing methods. Additionally, the growing need for self-diagnostic tools and the shift toward decentralized healthcare are expected to create future opportunities for market expansion. However, challenges such as the standardization between POC testing and centralized laboratory methods impact the broader adoption of these diagnostic solutions.

Point of Care Diagnostics Market Overview

The Point of Care (POC) Diagnostics Market is evolving, with the increasing demand for immediate and accurate diagnostic solutions. POC testing is conducted near the site of patient care, allowing for quick results that facilitate timely decision-making in clinical settings. This demand for this testing is influenced by the rising prevalence of infectious diseases and chronic conditions, which necessitate rapid diagnostic capabilities.

Innovations such as portable diagnostic devices and integrated digital health solutions enhance testing efficiency and accessibility. The shift toward decentralized healthcare models propels patients and healthcare providers to seek more convenient testing options that can be performed outside traditional laboratory settings.

Overall, the POC diagnostics market is poised for substantial growth, driven by the need for rapid testing solutions and the ongoing advancements in diagnostic technologies.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Point of Care Diagnostics Market: Strategic Insights

point-of-care-diagnostics-market
Market Size Value inUS$ 36,000.4 Million in 2021
Market Size Value byUS$ 82,958.3 Million by 2028
Growth rateCAGR of 12.7% from 2021-2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Point of Care Diagnostics Market Drivers and Opportunities

Key Product Launches and Developments 

The number of point-of-care tests has increased since its introduction. It is expected to grow with new product launches intended at delivering inexpensive care at the facilities at the closest possible distance from the patients' location. New products or technologies are being introduced to enhance the effectiveness of devices with incremental improvements in analytical performance. The growth of the point of care diagnostics market is driven by the introduction of new devices to perform molecular tests. New devices launched in the recent years include:

• In June 2023, Sysmex Corporation launched a point-of-care testing system in Europe to detect antimicrobial susceptibility. The system identifies the presence or absence of bacteria and evaluates the effectiveness of antimicrobials using patient urine samples suspected of having UTIs.

• In January 2023, Cipla Limited launched Cippoint, a point-of-care testing device. This device provides testing parameters such as cardiac markers, infectious diseases, diabetes, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved, which indicates that the device is approved by the European In-Vitro Diagnostic Device Directive, providing reliable testing solutions.

• In July 2021, QuantuMDx launched the Q-POC rapid PCR point-of-care diagnostic system, with its first test, a SARS-CoV-2 detection assay, now CE-IVD marked for use in Europe under the In Vitro Diagnostics Directive (98/79/EC).

Thus, increasing product launches by the market players propels the growth of the POC diagnostics market.

Rising Product Launches and Advancements by Market Players in Emerging Economies

For business expansion, market players are focusing on emerging nations, such as India, China, and Brazil, due to the large population suffering from HIV and other infectious diseases. According to the Press Information Bureau 2023 report, ~2.5 million people are living with HIV in India, with a prevalence rate of 0.2%, and 66,400 new HIV infections are reported in India annually. The increasing product launches indicate a potential environment for the adoption of advanced point-of-care diagnostic kits. In January 2022, Mylab launched the CoviSwift POC testing solution in India, which can be used in small labs, in-hospital labs, airports, and villages and allows gold-standard testing at high throughputs anywhere. The solution encompasses the CoviSwift assay and Compact-Q machines that process 16 samples within 40 minutes, which is approximately 4 times faster than traditional RT-PCR testing while maintaining high precision.

Advancements in nanotechnology and genomics are increasing the demand for diagnostics in the healthcare sector, encouraging the introduction of a greater number of point-of-care test systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. The development of nanomaterials and nanotechnology has promoted the progress of POCT platforms, which are used in colorimetric, optical, electrochemical, magnetic, and catalytic approaches. The point of care testing platforms are used to detect nucleic acids, proteins, pesticides, viruses, bio-markers in disease diagnosis, and even heavy-metal species. Thus, rising product launches and advancements in emerging countries are anticipated to provide ample growth opportunities for the point-of-care diagnostics market during the forecast period.

Point of Care Diagnostics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Point of Care Diagnostics Market analysis are product, purchase mode, sample, end user, and geography.

  • Based on product, the point of care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, thyroid testing, and others. The glucose monitoring segment held the largest share of the point of care diagnostics market in 2024, and it is expected to register a significant CAGR during 2024–2031.
  • By purchase mode, the market is categorized into OTC and prescription. The prescription segment held a larger share of the point of care diagnostics market in 2024.
  • As per sample, the point of care diagnostics market is segmented into blood, urine, and others. The blood segment held the largest share of the point of care diagnostics market in 2024, and it is expected to register a significant CAGR during 2024–2031.
  • Per end user, the Point of Care Diagnostics Market is segmented into healthcare facilities, homecare, and others. The healthcare facilities segment held the largest share of the Point of Care Diagnostics Market in 2024, and it is expected to register a significant CAGR during 2024–2031.

Point of Care Diagnostics Market Share Analysis by Geography

The geographic scope of the Point of Care Diagnostics Market report is mainly divided into five major regions: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America region is leading the market due to its robust healthcare infrastructure and early adoption of innovative diagnostic technologies. Canada ranks eighth among the largest medical device markets. According to the Government of Canada 2023 report, the prevalence of diabetes is rising at a significant pace. ~3.7 million population of the country (which is 9.4% of the total population) are living with diabetes or prediabetic conditions. The association has stated that every three minutes, a person is diagnosed with diabetes. Additionally, according to a report published by the government of Canada, the prevalence of HIV in Canada has grown by ~35.2% since 2022, and 2,434 new HIV cases reported in 2023. As per the Canadian Cancer Society, cancer was one of the primary reasons for deaths in the country, as the condition caused ~30% of deaths in 2023. Lung, breast, colorectal, and prostate cancer conditions predominated the diagnoses and deaths, with more than 46% share.

In July 2023, Fortis Life Sciences, LLC acquired Toronto-based International Point of Care, Inc. (IPOC). IPOC develops and manufactures components used in diagnostics, including lyophilized reagents, membranes, recombinant proteins, and controls. With this acquisition, Fortis can provide its customers with a customizable, end-to-end solution to advance their immunodiagnostic and molecular diagnostic products. IPOC’s recently expanded 36,000 sq. ft. facility is Fortis’ third GMP and ISO 13485-compliant manufacturing site in North America. Thus, the surging prevalence of cancer, the rising incidence of other diseases, and strategic collaborations fuel the growth of the point of care diagnostics market in the country.

Digital PCR and Real-Time PCR Market Report Scope

Point of Care Diagnostics Market News and Recent Developments

The Point of Care Diagnostics Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are listed below:

  • bioMérieux, a leader in the field of in vitro diagnostics, announced that it has entered into an agreement to acquire SpinChip Diagnostics ASA (“SpinChip”). This privately held Norwegian diagnostics company has developed a game-changing immunoassay diagnostics platform. The small benchtop analyzer is adapted to near patient testing as it can deliver a result from a whole blood sample within 10 minutes with the same high-sensitivity performance as the laboratory instruments. bioMérieux has held a minority stake in SpinChip since March 2024. (Source: bioMérieux, Company Website, January 2025)
  • Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology following the receipt of all required antitrust and regulatory clearances. Roche will now integrate the company’s multi-assay point of care platform and the related R&D, operational, and commercial sites into its global organization. (Source: Roche, Company Website, July 2024).

Point of Care Diagnostics Market Report Coverage and Deliverables

The "Point of Care Diagnostics Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Point of Care Diagnostics Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Point of Care Diagnostics Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Digital PCR and real-time PCR market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the digital PCR and real-time PCR market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product , Prescription Mode , and End User , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What would be the estimated value of the digital PCR and real-time PCR market by 2031?

The market value is expected to reach US$ 88.83 billion by 2031.

Which are the leading players operating in the digital PCR and real-time PCR market?

BD, Abbott, Johnson and Johnson Services, Inc., F. HOFFMANN-LA ROCHE LTD, Siemens AG, Danaher, BIO-RAD LABORATORIES INC, BioMerieux SA, Polymer Technology Systems, Inc. (PTS), Nova Biomedical are key players in the market.

What are the future trends in the digital PCR and real-time PCR market?

Integration of artificial intelligence (AI) and machine learning (ML) is expected to be a prime trend in the market in the coming years.

What are the factors driving the digital PCR and real-time PCR market growth?

The increasing prevalence of infectious diseases and key product launches and developments fuel the market growth.

What is the expected CAGR of the digital PCR and real-time PCR market?

The market is expected to register a CAGR of 13.0% during 2024–2031.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Point of Care Diagnostics Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Point of Care Diagnostics Market – Key Market Dynamics

5.1 Point of Care Diagnostics Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Increasing Prevalence of Infectious Diseases

5.2.2 Key Product Launches and Developments

5.3 Market Restraints

5.3.1 Product Recalls

5.4 Market Opportunities

5.4.1 Rising Product Launches and Advancements by Market Players in Emerging Economies

5.5 Future Trends

5.5.1 Integration Of Artificial Intelligence (AI) and Machine Learning (ML)

5.6 Impact of Drivers and Restraints:

6. Point of Care Diagnostics Market – Global Market Analysis

6.1 Point of Care Diagnostics Market Revenue (US$ Million), 2021–2031

6.2 Point of Care Diagnostics Market Forecast Analysis

7. Point of Care Diagnostics Market Analysis – by Product

7.1 Glucose Monitoring

7.1.1 Overview

7.1.2 Glucose Monitoring: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Infectious Disease Testing

7.2.1 Overview

7.2.2 Infectious Disease Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Cardio metabolic Testing

7.3.1 Overview

7.3.2 Cardio metabolic Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Pregnancy And Fertility Testing

7.4.1 Overview

7.4.2 Pregnancy And Fertility Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Coagulation Testing

7.5.1 Overview

7.5.2 Coagulation Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Tumor or Cancer Marker Testing

7.6.1 Overview

7.6.2 Tumor or Cancer Marker Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Cholesterol Testing

7.7.1 Overview

7.7.2 Cholesterol Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Urinalysis Testing

7.8.1 Overview

7.8.2 Urinalysis Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.9 Hematology Testing

7.9.1 Overview

7.9.2 Hematology Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.10 Thyroid Testing

7.10.1 Overview

7.10.2 Thyroid Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.11 Others

7.11.1 Overview

7.11.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Point of Care Diagnostics Market Analysis – by Purchase Mode

8.1 OTC

8.1.1 Overview

8.1.2 OTC: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Prescription

8.2.1 Overview

8.2.2 Prescription: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

9. Point of Care Diagnostics Market Analysis – by Sample

9.1 Blood

9.1.1 Overview

9.1.2 Blood: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Urine

9.2.1 Overview

9.2.2 Urine: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Others

9.3.1 Overview

9.3.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

10. Point of Care Diagnostics Market Analysis – by End User

10.1 Healthcare Facilities

10.1.1 Overview

10.1.2 Healthcare Facilities: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

10.2 Homecare

10.2.1 Overview

10.2.2 Homecare: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

10.3 Others

10.3.1 Overview

10.3.2 Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

11. Point of Care Diagnostics Market – Geographical Analysis

11.1 Overview

11.2 North America

11.2.1 North America Point of Care Diagnostics Market Overview

11.2.2 North America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.2.3 North America: Point of Care Diagnostics Market Breakdown, by Product

11.2.3.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product

11.2.3.2 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring

11.2.3.3 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing

11.2.3.4 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing

11.2.4 North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.2.4.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode

11.2.5 North America: Point of Care Diagnostics Market Breakdown, by Sample

11.2.5.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample

11.2.6 North America: Point of Care Diagnostics Market Breakdown, by End User

11.2.6.1 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User

11.2.6.2 North America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities

11.2.7 North America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.2.7.1 North America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.2.7.2 United States: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.2.7.2.1 United States: Point of Care Diagnostics Market Breakdown, by Product

11.2.7.2.2 United States: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.2.7.2.3 United States: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.2.7.2.4 United States: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.2.7.2.5 United States: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.2.7.2.6 United States: Point of Care Diagnostics Market Breakdown, by Sample

11.2.7.2.7 United States: Point of Care Diagnostics Market Breakdown, by End User

11.2.7.2.8 United States: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.2.7.3 Canada: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.2.7.3.1 Canada: Point of Care Diagnostics Market Breakdown, by Product

11.2.7.3.2 Canada: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.2.7.3.3 Canada: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.2.7.3.4 Canada: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.2.7.3.5 Canada: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.2.7.3.6 Canada: Point of Care Diagnostics Market Breakdown, by Sample

11.2.7.3.7 Canada: Point of Care Diagnostics Market Breakdown, by End User

11.2.7.3.8 Canada: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.2.7.4 Mexico: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.2.7.4.1 Mexico: Point of Care Diagnostics Market Breakdown, by Product

11.2.7.4.2 Mexico: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.2.7.4.3 Mexico: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.2.7.4.4 Mexico: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.2.7.4.5 Mexico: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.2.7.4.6 Mexico: Point of Care Diagnostics Market Breakdown, by Sample

11.2.7.4.7 Mexico: Point of Care Diagnostics Market Breakdown, by End User

11.2.7.4.8 Mexico: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3 Europe

11.3.1 EuropePoint of Care Diagnostics Market Overview

11.3.2 Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.3 Europe: Point of Care Diagnostics Market Breakdown, by Product

11.3.3.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product

11.3.3.2 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring

11.3.3.3 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing

11.3.3.4 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing

11.3.4 Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.4.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode

11.3.5 Europe: Point of Care Diagnostics Market Breakdown, by Sample

11.3.5.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample

11.3.6 Europe: Point of Care Diagnostics Market Breakdown, by End User

11.3.6.1 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User

11.3.6.2 Europe: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities

11.3.7 Europe: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.3.7.1 Europe: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.3.7.2 United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.2.1 United Kingdom: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.2.2 United Kingdom: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.2.3 United Kingdom: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.2.4 United Kingdom: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.2.5 United Kingdom: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.2.6 United Kingdom: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.2.7 United Kingdom: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.2.8 United Kingdom: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3.7.3 Germany: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.3.1 Germany: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.3.2 Germany: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.3.3 Germany: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.3.4 Germany: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.3.5 Germany: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.3.6 Germany: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.3.7 Germany: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.3.8 Germany: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3.7.4 France: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.4.1 France: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.4.2 France: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.4.3 France: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.4.4 France: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.4.5 France: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.4.6 France: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.4.7 France: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.4.8 France: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3.7.5 Italy: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.5.1 Italy: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.5.2 Italy: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.5.3 Italy: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.5.4 Italy: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.5.5 Italy: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.5.6 Italy: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.5.7 Italy: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.5.8 Italy: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3.7.6 Spain: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.6.1 Spain: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.6.2 Spain: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.6.3 Spain: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.6.4 Spain: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.6.5 Spain: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.6.6 Spain: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.6.7 Spain: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.6.8 Spain: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.3.7.7 Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.3.7.7.1 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Product

11.3.7.7.2 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.3.7.7.3 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.3.7.7.4 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.3.7.7.5 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.3.7.7.6 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Sample

11.3.7.7.7 Rest of Europe: Point of Care Diagnostics Market Breakdown, by End User

11.3.7.7.8 Rest of Europe: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4 Asia Pacific

11.4.1 Asia PacificPoint of Care Diagnostics Market Overview

11.4.2 Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.3 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product

11.4.3.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product

11.4.3.2 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring

11.4.3.3 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing

11.4.3.4 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing

11.4.4 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.4.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode

11.4.5 Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample

11.4.5.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample

11.4.6 Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User

11.4.6.1 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User

11.4.6.2 Asia Pacific: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities

11.4.7 Asia Pacific: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.4.7.1 Asia Pacific: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.4.7.2 China: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.2.1 China: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.2.2 China: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.2.3 China: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.2.4 China: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.2.5 China: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.2.6 China: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.2.7 China: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.2.8 China: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4.7.3 Japan: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.3.1 Japan: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.3.2 Japan: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.3.3 Japan: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.3.4 Japan: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.3.5 Japan: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.3.6 Japan: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.3.7 Japan: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.3.8 Japan: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4.7.4 India: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.4.1 India: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.4.2 India: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.4.3 India: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.4.4 India: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.4.5 India: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.4.6 India: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.4.7 India: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.4.8 India: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4.7.5 Australia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.5.1 Australia: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.5.2 Australia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.5.3 Australia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.5.4 Australia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.5.5 Australia: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.5.6 Australia: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.5.7 Australia: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.5.8 Australia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4.7.6 South Korea: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.6.1 South Korea: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.6.2 South Korea: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.6.3 South Korea: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.6.4 South Korea: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.6.5 South Korea: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.6.6 South Korea: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.6.7 South Korea: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.6.8 South Korea: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.4.7.7 Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.4.7.7.1 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Product

11.4.7.7.2 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.4.7.7.3 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.4.7.7.4 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.4.7.7.5 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.4.7.7.6 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Sample

11.4.7.7.7 Rest of APAC: Point of Care Diagnostics Market Breakdown, by End User

11.4.7.7.8 Rest of APAC: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.5 Middle East and Africa

11.5.1 Middle East and AfricaPoint of Care Diagnostics Market Overview

11.5.2 Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.5.3 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product

11.5.3.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product

11.5.3.2 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring

11.5.3.3 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing

11.5.3.4 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing

11.5.4 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.5.4.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode

11.5.5 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample

11.5.5.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample

11.5.6 Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User

11.5.6.1 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User

11.5.6.2 Middle East and Africa: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities

11.5.7 Middle East and Africa: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.5.7.1 Middle East and Africa: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.5.7.2 South Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.5.7.2.1 South Africa: Point of Care Diagnostics Market Breakdown, by Product

11.5.7.2.2 South Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.5.7.2.3 South Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.5.7.2.4 South Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.5.7.2.5 South Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.5.7.2.6 South Africa: Point of Care Diagnostics Market Breakdown, by Sample

11.5.7.2.7 South Africa: Point of Care Diagnostics Market Breakdown, by End User

11.5.7.2.8 South Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.5.7.3 Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.5.7.3.1 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Product

11.5.7.3.2 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.5.7.3.3 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.5.7.3.4 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.5.7.3.5 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.5.7.3.6 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Sample

11.5.7.3.7 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by End User

11.5.7.3.8 Saudi Arabia: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.5.7.4 United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.5.7.4.1 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Product

11.5.7.4.2 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.5.7.4.3 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.5.7.4.4 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.5.7.4.5 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.5.7.4.6 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Sample

11.5.7.4.7 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by End User

11.5.7.4.8 United Arab Emirates: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.5.7.5 Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.5.7.5.1 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product

11.5.7.5.2 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.5.7.5.3 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.5.7.5.4 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.5.7.5.5 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.5.7.5.6 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample

11.5.7.5.7 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User

11.5.7.5.8 Rest of Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.6 South and Central America

11.6.1 South and Central America Point of Care Diagnostics Market Overview

11.6.2 South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.6.3 South and Central America: Point of Care Diagnostics Market Breakdown, by Product

11.6.3.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Product

11.6.3.2 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Glucose Monitoring

11.6.3.3 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Infectious Disease Testing

11.6.3.4 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Cardio Metabolic Testing

11.6.4 South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.6.4.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Purchase Mode

11.6.5 South and Central America: Point of Care Diagnostics Market Breakdown, by Sample

11.6.5.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Sample

11.6.6 South and Central America: Point of Care Diagnostics Market Breakdown, by End User

11.6.6.1 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by End User

11.6.6.2 South and Central America: Point of Care Diagnostics Market– Revenue and Forecast Analysis – by Healthcare Facilities

11.6.7 South and Central America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.6.7.1 South and Central America: Point of Care Diagnostics Market – Revenue and Forecast Analysis – by Country

11.6.7.2 Brazil: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.6.7.2.1 Brazil: Point of Care Diagnostics Market Breakdown, by Product

11.6.7.2.2 Brazil: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.6.7.2.3 Brazil: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.6.7.2.4 Brazil: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.6.7.2.5 Brazil: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.6.7.2.6 Brazil: Point of Care Diagnostics Market Breakdown, by Sample

11.6.7.2.7 Brazil: Point of Care Diagnostics Market Breakdown, by End User

11.6.7.2.8 Brazil: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.6.7.3 Argentina: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.6.7.3.1 Argentina: Point of Care Diagnostics Market Breakdown, by Product

11.6.7.3.2 Argentina: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.6.7.3.3 Argentina: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.6.7.3.4 Argentina: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.6.7.3.5 Argentina: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.6.7.3.6 Argentina: Point of Care Diagnostics Market Breakdown, by Sample

11.6.7.3.7 Argentina: Point of Care Diagnostics Market Breakdown, by End User

11.6.7.3.8 Argentina: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

11.6.7.4 Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

11.6.7.4.1 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Product

11.6.7.4.2 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Glucose Monitoring

11.6.7.4.3 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Infectious Disease Testing

11.6.7.4.4 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Cardio Metabolic Testing

11.6.7.4.5 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode

11.6.7.4.6 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Sample

11.6.7.4.7 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by End User

11.6.7.4.8 Rest of South and Central America: Point of Care Diagnostics Market Breakdown, by Healthcare Facilities

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players

12.2 Company Market Share Analysis, 2024

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Merger and Acquisition

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Beckman Coulter Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Bio-Rad Laboratories Inc

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Abbott Laboratories

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Johnson & Johnson

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Siemens AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 BD

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 bioMerieux SA

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Polymer Technology Systems, Inc. (PTS)

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Nova Biomedical Corporation

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Talis Biomedical Corporation

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 QuidelOrtho Corp

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

14.13 Chembio Diagnostics, Inc.

14.13.1 Key Facts

14.13.2 Business Description

14.13.3 Products and Services

14.13.4 Financial Overview

14.13.5 SWOT Analysis

14.13.6 Key Developments

15. Appendix

15.1 About The Insight Partners

List of Tables

Table 1. Point of Care Diagnostics Market Segmentation

Table 2. List of Vendors

Table 3. Point of Care Diagnostics Market – Revenue, 2021- 2024 (US$ Million)

Table 4. Point of Care Diagnostics Market – Revenue, 2025- 2031 (US$ Million)

Table 5. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 6. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Product

Table 7. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 8. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Purchase Mode

Table 9. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 10. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by Sample

Table 11. Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 12. Point of Care Diagnostics Market – Revenue, 2025 - 2031(US$ Million) – by End User

Table 13. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product

Table 14. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 15. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring

Table 16. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 17. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing

Table 18. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 19. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing

Table 20. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 21. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode

Table 22. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 23. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample

Table 24. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 25. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User

Table 26. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 27. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities

Table 28. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 29. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country

Table 30. North America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country

Table 31. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 32. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 33. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 34. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 35. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 36. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 37. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 38. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 39. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 40. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 41. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 42. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 43. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 44. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 45. United States: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 46. United States: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 47. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 48. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 49. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 50. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 51. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 52. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 53. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 54. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 55. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 56. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 57. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 58. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 59. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 60. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 61. Canada: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 62. Canada: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 63. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 64. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 65. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 66. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 67. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 68. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 69. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 70. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 71. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 72. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 73. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 74. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 75. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 76. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 77. Mexico: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 78. Mexico: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 79. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product

Table 80. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 81. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring

Table 82. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 83. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing

Table 84. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 85. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing

Table 86. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 87. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode

Table 88. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 89. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample

Table 90. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 91. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User

Table 92. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 93. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities

Table 94. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 95. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country

Table 96. Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country

Table 97. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 98. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 99. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 100. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 101. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 102. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 103. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 104. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 105. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 106. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 107. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 108. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 109. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 110. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 111. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 112. United Kingdom: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 113. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 114. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 115. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 116. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 117. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 118. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 119. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 120. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 121. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 122. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 123. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 124. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 125. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 126. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 127. Germany: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 128. Germany: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 129. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 130. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 131. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 132. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 133. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 134. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 135. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 136. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 137. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 138. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 139. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 140. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 141. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 142. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 143. France: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 144. France: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 145. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 146. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 147. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 148. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 149. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 150. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 151. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 152. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 153. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 154. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 155. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 156. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 157. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 158. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 159. Italy: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 160. Italy: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 161. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 162. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 163. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 164. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 165. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 166. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 167. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 168. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 169. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 170. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 171. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 172. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 173. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 174. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 175. Spain: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 176. Spain: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 177. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 178. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 179. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 180. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 181. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 182. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 183. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 184. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 185. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 186. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 187. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 188. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 189. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 190. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 191. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 192. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 193. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product

Table 194. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 195. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring

Table 196. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 197. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing

Table 198. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 199. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing

Table 200. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 201. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode

Table 202. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 203. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample

Table 204. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 205. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User

Table 206. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 207. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities

Table 208. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 209. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country

Table 210. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country

Table 211. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 212. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 213. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 214. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 215. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 216. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 217. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 218. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 219. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 220. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 221. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 222. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 223. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 224. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 225. China: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 226. China: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 227. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 228. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 229. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 230. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 231. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 232. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 233. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 234. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 235. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 236. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 237. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 238. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 239. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 240. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 241. Japan: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 242. Japan: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 243. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 244. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 245. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 246. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 247. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 248. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 249. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 250. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 251. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 252. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 253. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 254. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 255. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 256. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 257. India: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 258. India: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 259. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 260. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 261. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 262. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 263. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 264. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 265. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 266. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 267. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 268. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 269. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 270. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 271. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 272. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 273. Australia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 274. Australia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 275. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 276. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 277. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 278. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 279. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 280. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 281. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 282. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 283. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 284. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 285. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 286. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 287. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 288. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 289. South Korea: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 290. South Korea: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 291. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 292. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 293. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 294. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 295. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 296. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 297. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 298. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 299. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 300. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 301. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 302. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 303. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 304. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 305. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 306. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 307. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product

Table 308. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 309. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring

Table 310. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 311. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing

Table 312. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 313. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing

Table 314. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 315. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode

Table 316. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 317. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample

Table 318. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 319. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User

Table 320. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 321. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities

Table 322. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 323. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country

Table 324. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country

Table 325. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 326. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 327. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 328. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 329. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 330. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 331. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 332. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 333. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 334. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 335. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 336. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 337. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 338. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 339. South Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 340. South Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 341. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 342. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 343. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 344. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 345. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 346. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 347. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 348. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 349. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 350. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 351. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 352. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 353. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 354. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 355. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 356. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 357. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 358. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 359. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 360. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 361. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 362. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 363. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 364. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 365. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 366. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 367. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 368. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 369. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 370. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 371. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 372. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 373. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 374. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 375. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 376. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 377. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 378. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 379. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 380. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 381. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 382. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 383. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 384. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 385. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 386. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 387. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 388. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 389. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Product

Table 390. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 391. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Glucose Monitoring

Table 392. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 393. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Infectious Disease Testing

Table 394. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 395. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Cardio Metabolic Testing

Table 396. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 397. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Purchase Mode

Table 398. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 399. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Sample

Table 400. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 401. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by End User

Table 402. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 403. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Healthcare Facilities

Table 404. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 405. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2024 (US$ Million) – by Country

Table 406. South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Country

Table 407. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 408. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 409. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 410. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 411. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 412. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 413. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 414. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 415. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 416. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 417. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 418. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 419. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 420. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 421. Brazil: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 422. Brazil: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 423. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 424. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 425. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 426. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 427. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 428. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 429. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 430. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 431. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 432. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 433. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 434. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 435. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 436. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 437. Argentina: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 438. Argentina: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 439. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Product

Table 440. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Product

Table 441. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Glucose Monitoring

Table 442. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Glucose Monitoring

Table 443. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Infectious Disease Testing

Table 444. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Infectious Disease Testing

Table 445. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Cardio Metabolic Testing

Table 446. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Cardio Metabolic Testing

Table 447. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Purchase Mode

Table 448. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Purchase Mode

Table 449. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Sample

Table 450. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Sample

Table 451. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by End User

Table 452. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by End User

Table 453. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 -2024(US$ Million) – by Healthcare Facilities

Table 454. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2025 - 2031 (US$ Million) – by Healthcare Facilities

Table 455. Heat Map Analysis by Key Players

List of Figures

Figure 1. Point of Care Diagnostics Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Point of Care Diagnostics Market Revenue (US$ Million), 2021–2031

Figure 5. Point of Care Diagnostics Market Share (%) – by Product (2024 and 2031)

Figure 6. Glucose Monitoring: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Infectious Disease Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Cardio metabolic Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Pregnancy And Fertility Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Coagulation Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Tumor or Cancer Marker Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Cholesterol Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. Urinalysis Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Hematology Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Thyroid Testing: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Point of Care Diagnostics Market Share (%) – by Purchase Mode (2024 and 2031)

Figure 18. OTC: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Prescription: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20. Point of Care Diagnostics Market Share (%) – by Sample (2024 and 2031)

Figure 21. Blood: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22. Urine: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24. Point of Care Diagnostics Market Share (%) – by End User (2024 and 2031)

Figure 25. Healthcare Facilities: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26. Homecare: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27. Others: Point of Care Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

Figure 28. Point of Care Diagnostics Market Breakdown by Region, 2024 and 2031 (%)

Figure 29. North America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 30. North America: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)

Figure 31. North America: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)

Figure 32. North America: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)

Figure 33. North America: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)

Figure 34. North America: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 35. United States: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 36. Canada: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 37. Mexico: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 38. Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 39. Europe: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)

Figure 40. Europe: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)

Figure 41. Europe: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)

Figure 42. Europe: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)

Figure 43. Europe: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 44. United Kingdom: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 45. Germany: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 46. France: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 47. Italy: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 48. Spain: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 49. Rest of Europe: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 50. Asia Pacific: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 51. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)

Figure 52. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)

Figure 53. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)

Figure 54. Asia Pacific: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)

Figure 55. Asia Pacific: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 56. China: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 57. Japan: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 58. India: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 59. Australia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 60. South Korea: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 61. Rest of APAC: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 62. Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 63. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)

Figure 64. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)

Figure 65. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)

Figure 66. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)

Figure 67. Middle East and Africa: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 68. South Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 69. Saudi Arabia: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 70. United Arab Emirates: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 71. Rest of Middle East and Africa: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 72. South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 73. South and Central America: Point of Care Diagnostics Market Breakdown, by Product (2024 and 2031)

Figure 74. South and Central America: Point of Care Diagnostics Market Breakdown, by Purchase Mode (2024 and 2031)

Figure 75. South and Central America: Point of Care Diagnostics Market Breakdown, by Sample (2024 and 2031)

Figure 76. South and Central America: Point of Care Diagnostics Market Breakdown, by End User (2024 and 2031)

Figure 77. South and Central America: Point of Care Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 78. Brazil: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 79. Argentina: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 80. Rest of South and Central America: Point of Care Diagnostics Market – Revenue, 2021 - 2031 (US$ Million)

Figure 81. Company Market Share Analysis, 2024

The List of Companies - Point of Care Diagnostics Market 

  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Abbott Laboratories
  • QIAGEN NV
  • Siemens AG
  • BD
  • bioMerieux SA
  • Polymer Technology Systems, Inc. (PTS)
  • Nova Biomedical Corporation
  • Danaher Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Point of Care Diagnostics Market